Literature DB >> 25448479

Engineering PTEN function: membrane association and activity.

Jr-Ming Yang1, Hoai-Nghia Nguyen1, Hiromi Sesaki1, Peter N Devreotes1, Miho Iijima2.   

Abstract

Many tumors are associated with deficiency of the tumor suppressor, PTEN, a PIP3 phosphatase that turns off PIP3 signaling. The major site of PTEN action is the plasma membrane, where PIP3 is produced by PI3 kinases. However, the mechanism and functional importance of PTEN membrane recruitment are poorly defined. Using the heterologous expression system in which human PTEN is expressed in Dictyostelium discoideum, we defined the molecular mechanisms that regulate the membrane-binding site through inhibitory interactions with the phosphorylated C-terminal tail. In addition, we potentiated mechanisms that mediate PTEN membrane association and engineered an enhanced PTEN with increased tumor suppressor functions. Moreover, we identified a new class of cancer-associated PTEN mutations that are specifically defective in membrane association. In this review, we summarize recent advances in PTEN-membrane interactions and methods useful in addressing PTEN function.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dictyostelium; Membrane; Mutation; PIP3

Mesh:

Substances:

Year:  2014        PMID: 25448479      PMCID: PMC4388803          DOI: 10.1016/j.ymeth.2014.10.018

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  35 in total

1.  Myosin I links PIP3 signaling to remodeling of the actin cytoskeleton in chemotaxis.

Authors:  Chun-Lin Chen; Yu Wang; Hiromi Sesaki; Miho Iijima
Journal:  Sci Signal       Date:  2012-01-31       Impact factor: 8.192

Review 2.  Exploiting the PI3K/AKT pathway for cancer drug discovery.

Authors:  Bryan T Hennessy; Debra L Smith; Prahlad T Ram; Yiling Lu; Gordon B Mills
Journal:  Nat Rev Drug Discov       Date:  2005-12       Impact factor: 84.694

Review 3.  The functions and regulation of the PTEN tumour suppressor.

Authors:  Min Sup Song; Leonardo Salmena; Pier Paolo Pandolfi
Journal:  Nat Rev Mol Cell Biol       Date:  2012-04-04       Impact factor: 94.444

Review 4.  PTEN level in tumor suppression: how much is too little?

Authors:  Arkaitz Carracedo; Andrea Alimonti; Pier Paolo Pandolfi
Journal:  Cancer Res       Date:  2011-01-25       Impact factor: 12.701

5.  A comprehensive functional analysis of PTEN mutations: implications in tumor- and autism-related syndromes.

Authors:  Isabel Rodríguez-Escudero; María D Oliver; Amparo Andrés-Pons; María Molina; Víctor J Cid; Rafael Pulido
Journal:  Hum Mol Genet       Date:  2011-08-09       Impact factor: 6.150

6.  Analysis of chemotaxis in Dictyostelium.

Authors:  Huaqing Cai; Chuan-Hsiang Huang; Peter N Devreotes; Miho Iijima
Journal:  Methods Mol Biol       Date:  2012

7.  Lifetime cancer risks in individuals with germline PTEN mutations.

Authors:  Min-Han Tan; Jessica L Mester; Joanne Ngeow; Lisa A Rybicki; Mohammed S Orloff; Charis Eng
Journal:  Clin Cancer Res       Date:  2012-01-15       Impact factor: 12.531

8.  Single copies of mutant KRAS and mutant PIK3CA cooperate in immortalized human epithelial cells to induce tumor formation.

Authors:  Grace M Wang; Hong Yuen Wong; Hiroyuki Konishi; Brian G Blair; Abde M Abukhdeir; John P Gustin; D Marc Rosen; Samuel Ray Denmeade; Zeshaan Rasheed; William Matsui; Joseph P Garay; Morassa Mohseni; Michaela J Higgins; Justin Cidado; Danijela Jelovac; Sarah Croessmann; Rory L Cochran; Sivasundaram Karnan; Yuko Konishi; Akinobu Ota; Yoshitaka Hosokawa; Pedram Argani; Josh Lauring; Ben Ho Park
Journal:  Cancer Res       Date:  2013-04-11       Impact factor: 12.701

9.  PI3K signalling: the path to discovery and understanding.

Authors:  Bart Vanhaesebroeck; Len Stephens; Phillip Hawkins
Journal:  Nat Rev Mol Cell Biol       Date:  2012-02-23       Impact factor: 94.444

10.  Dictyostelium huntingtin controls chemotaxis and cytokinesis through the regulation of myosin II phosphorylation.

Authors:  Yu Wang; Paul A Steimle; Yixin Ren; Christopher A Ross; Douglas N Robinson; Thomas T Egelhoff; Hiromi Sesaki; Miho Iijima
Journal:  Mol Biol Cell       Date:  2011-05-11       Impact factor: 4.138

View more
  5 in total

1.  Generating a new mouse model for nuclear PTEN deficiency by a single K13R mutation.

Authors:  Takashi Kato; Atsushi Igarashi; Hiromi Sesaki; Miho Iijima
Journal:  Genes Cells       Date:  2021-10-28       Impact factor: 1.891

2.  Characterization of PTEN mutations in brain cancer reveals that pten mono-ubiquitination promotes protein stability and nuclear localization.

Authors:  Jr-M Yang; P Schiapparelli; H-N Nguyen; A Igarashi; Q Zhang; S Abbadi; L M Amzel; H Sesaki; A Quiñones-Hinojosa; M Iijima
Journal:  Oncogene       Date:  2017-03-06       Impact factor: 9.867

Review 3.  Forecast of actin-binding proteins as the oncotarget in osteosarcoma - a review of mechanism, diagnosis and therapy.

Authors:  Yucheng Fu; Wei Yu; Hongliu Cai; Anwei Lu
Journal:  Onco Targets Ther       Date:  2018-03-20       Impact factor: 4.147

Review 4.  Planet of the AAVs: The Spinal Cord Injury Episode.

Authors:  Katerina Stepankova; Pavla Jendelova; Lucia Machova Urdzikova
Journal:  Biomedicines       Date:  2021-05-28

5.  Opening the conformation is a master switch for the dual localization and phosphatase activity of PTEN.

Authors:  Hoai-Nghia Nguyen; Jr-Ming Yang; Takafumi Miyamoto; Kie Itoh; Elmer Rho; Qiang Zhang; Takanari Inoue; Peter N Devreotes; Hiromi Sesaki; Miho Iijima
Journal:  Sci Rep       Date:  2015-07-28       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.